摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-isobutyl-3-phenyl-[1,2,4]oxadiazole | 4969-63-5

中文名称
——
中文别名
——
英文名称
5-isobutyl-3-phenyl-[1,2,4]oxadiazole
英文别名
5-Isobutyl-3-phenyl-[1,2,4]oxadiazol;5-Isobutyl-3-phenyl-1,2,4-oxadiazol;5-(2-Methylpropyl)-3-phenyl-1,2,4-oxadiazole
5-isobutyl-3-phenyl-[1,2,4]oxadiazole化学式
CAS
4969-63-5
化学式
C12H14N2O
mdl
——
分子量
202.256
InChiKey
ISNWTPWEFMGFJU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    83-84 °C(Press: 0.04 Torr)
  • 密度:
    1.063±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    38.9
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • BRIDGED CARBAMATE MACROLIDES
    申请人:Kim Heejin
    公开号:US20080027012A1
    公开(公告)日:2008-01-31
    The present invention discloses compounds of formulae (I) and (II) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
    本发明公开了式(I)和(II)的化合物或其药学上可接受的盐、酯或前药:这些化合物具有抗菌性能。本发明还涉及含有上述化合物的药物组合物,用于治疗需要抗生素治疗的受试者。该发明还涉及通过给予含有本发明化合物的药物组合物来治疗受试者的细菌感染的方法。该发明还包括制备本发明化合物的方法。
  • C-9 ALKENYLIDINE BRIDGED MACROLIDES
    申请人:Phan Ly Tam
    公开号:US20080119418A1
    公开(公告)日:2008-05-22
    The present invention discloses compounds of formulae (I), (II) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
    本发明揭示了以下化合物的公式(I),(II)或其药学上可接受的盐,酯或前药:具有抗菌性质。本发明还涉及包括上述化合物的制药组合物,用于治疗需要抗生素治疗的受体。本发明还涉及通过给予包含本发明化合物的制药组合物来治疗受体的细菌感染的方法。本发明还包括制备本发明化合物的方法。
  • 3,6-Bridged 9,12-oxolides
    申请人:Or Sun Yat
    公开号:US20070232554A1
    公开(公告)日:2007-10-04
    The present invention discloses compounds of formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
    本发明揭示了公式(I)的化合物或其药学上可接受的盐、酯或前药:具有抗菌性能。本发明还涉及包含上述化合物的制药组合物,用于治疗需要抗生素治疗的受体。本发明还涉及通过给予包含本发明化合物的制药组合物来治疗受体的细菌感染的方法。本发明还包括制备本发明化合物的方法。
  • Lenaers,R.; Eloy,F., Helvetica Chimica Acta, 1963, vol. 46, p. 1067 - 1073
    作者:Lenaers,R.、Eloy,F.
    DOI:——
    日期:——
  • 6-11 Bicyclic Ketolide Derivatives
    申请人:Or Yat Sun
    公开号:US20070244160A1
    公开(公告)日:2007-10-18
    The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
查看更多